| Report ID | 283097 |
| Drug Identification Number | 02239327 |
| Brand name | TRYPTAN |
| Common or Proper name | TRYPTAN |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | TRYPTOPHAN |
| Strength(s) | 750MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 TB |
| Anatomical Therapeutical Chemical (ATC) code | N06AX |
| Anatomical Therapeutical Chemical (ATC) description | ANTIDEPRESSANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-08-31 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-16 | French | Compare |
| v1 | 2026-04-16 | English | Compare |
Showing 1 to 2 of 2